Thursday, June 11, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 125 of 200 Β· By data quality, then INN

  1. formoterol

    FORADILE AstraZeneca

    EMA: approved Β· TGA: approved

    R03AL
  2. formoterol (fumarate)

    ZENHALE

    EMA: application withdrawn

    R03AK07
  3. formoterol fumarate dihydrate

    RILTRAVA AEROSPHERE

    EMA: approved

    R03AL11
  4. fosamprenavir

    TELZIR

    EMA: withdrawn

    J05AE07
  5. fosaprepitant

    FOSAPREPITANT MEDSURGE Lacuna Pharma Pty Ltd

    EMA: approved Β· TGA: approved

    A04AD12
  6. fosdenopterin

    NULIBRY

    EMA: approved

    A16AX19
  7. fostamatinib

    TAVLESSE

    EMA: approved

    B02BX
  8. fostemsavir

    RUKOBIA

    EMA: approved

    J05AX
  9. galcanezumab

    EMGALITY

    EMA: approved Β· TGA: approved Β· PMDA: approved

    N02
  10. gallium (68ga) chloride

    GALLIAPHARM

    EMA: approved

    V09X
  11. ganirelix

    ARX GANIRELIX Alphapharm Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    H01CC01
  12. garadacimab

    ANDEMBRY

    EMA: approved Β· PMDA: approved

    B06AC07
  13. garenoxacin mesylate

    GARENOXACIN MESYLATE

    EMA: application withdrawn

  14. gbp510

    SKYCOVION

    EMA: application withdrawn

    J07BX03
  15. gefapixant

    LYFNUA

    EMA: approved

    R05DB29
  16. germanium (68ge) chloride

    GALENVITA

    EMA: approved

    V09X
  17. gilteritinib

    XOSPATA Astellas Pharma Inc

    EMA: approved Β· TGA: approved

    L01EX13
  18. givinostat

    DUVYZAT

    EMA: approved

    M09AX14
  19. glasdegib

    DAURISMO

    EMA: approved

    L01XX63
  20. glibenclamide

    DAONIL Sanofi-aventis Healthcare Pty Ltd

    EMA: approved Β· TGA: approved

    A10BB01
  21. glofitamab

    COLUMVI Hoffmann-La Roche

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01FX28
  22. glycopyrronium

    AXHIDROX Novartis Pharmaceuticals

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    R03AL07
  23. glycopyrronium bromide

    ENUREV BREEZHALER

    EMA: approved Β· PMDA: approved

    R03BB06
  24. govorestat

    NUGALVIQ

    EMA: application withdrawn

    A16AX24

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.